BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1812481)

  • 1. [Pharmacokinetics and pharmacodynamics of twice-daily unequal administration of theophylline retard pellets in children of various age groups].
    Berdel D; von Berg A; Reinhardt D; Heimann G; Steinijans VW; Sauter R
    Pneumologie; 1991 Nov; 45 Suppl 4():863-6. PubMed ID: 1812481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [24-hour lung function in asthmatic patients: chrono-optimal theophylline therapy as once-daily Euphylong administration vs conventional twice-daily administration].
    D'Alonzo GE; Smolensky MH; Feldman S; Gianotti LA; Emerson MB; Staudinger HW; Sauter R; Steinijans VW
    Pneumologie; 1991 Nov; 45 Suppl 4():834-41. PubMed ID: 1812476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of serum concentrations of once and twice daily administration of ultra-retard theophylline in school children with bronchial asthma].
    Liebke C; Niggemann B; Wahn U
    Pneumologie; 1996 Nov; 50(11):752-5. PubMed ID: 9082442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic profile of a new sustained-release theophylline pellet formulation for once-daily evening administration.
    Steinijans VW; Sauter R; Böhm A; Staudinger H
    Arzneimittelforschung; 1988 Aug; 38(8A):1241-50. PubMed ID: 3190813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronotherapy concept and the pharmacokinetic validation of a theophylline retard preparation for once-nightly administration (Euphylong)].
    Steinijans VW; Sauter R; Böhm A; Dietrich R; Benedikt G
    Pneumologie; 1991 Nov; 45 Suppl 4():827-33. PubMed ID: 1812475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of once-daily theophylline dose following the morning versus evening administration.
    Trnavská Z; Vondra V; Elis J
    Arzneimittelforschung; 1989 Sep; 39(9):1149-51. PubMed ID: 2590267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Euphylong in patients with chronic obstructive airway diseases].
    Kublik A; von Wichert P
    Pneumologie; 1991 Nov; 45 Suppl 4():858-62. PubMed ID: 1812480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steady-state pharmacokinetics of a once-daily theophylline formulation (Euphylong) when given twice daily.
    Götz J; Sauter R; Steinijans VW; Jonkman JH
    Int J Clin Pharmacol Ther; 1994 Apr; 32(4):168-73. PubMed ID: 8032575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multicenter study with a large number of patients for the validation of pharmacokinetic and clinical findings from controlled studies with small patient cohorts].
    Götz JK; Sauter R
    Pneumologie; 1991 Nov; 45 Suppl 4():867-74. PubMed ID: 1812482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Euphylong in standard dosage: comparison with an international retard preparation for twice-daily administration in recommended dosage].
    Siemon G; Huber W; Maier-Stocker P
    Pneumologie; 1991 Nov; 45 Suppl 4():853-7. PubMed ID: 1812479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variations in theophylline concentrations detected by 24-hour saliva concentration profiles in ambulatory children with asthma.
    Tal A; Aviram M; Gorodischer R
    J Allergy Clin Immunol; 1990 Aug; 86(2):238-43. PubMed ID: 2384651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steady state pharmacokinetics, metabolism and pharmacodynamics of theophylline in children after unequal twice-daily dosing of a new sustained-release formulation.
    Reinhardt D; Berdel D; Heimann G; Kusenbach G; von Berg A; Johnson E; Steinijans VW; Staudinger H
    Chronobiol Int; 1987; 4(3):369-80. PubMed ID: 3677217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetics and chronotherapy of delayed action theophylline (Euphyllin CR)].
    Vondra V; Spicák V; Trnavská Z; Reisová M; Pohunek P; Tomíska F
    Cas Lek Cesk; 1989 May; 128(19):595-8. PubMed ID: 2743384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theophylline administration in children with asthma: optimal pulmonary function and possible tolerance to chronic administration.
    Katz RM; Rachelefsky GS; Siegel SC; Mickey R
    Ann Allergy; 1983 Jan; 50(1):23-6. PubMed ID: 6849515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability of a slow-release theophylline capsule given twice daily to preschool children with chronic asthma: comparison with liquid theophylline.
    Sallent J; Hill M; Stecenko A; McKenzie M; Hendeles L
    Pediatrics; 1988 Jan; 81(1):116-20. PubMed ID: 3336577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adaptation of the oral dosage of theophylline to the asthmatic child. Value of a kinetic test by the intravenous route].
    Albertini M; Lapalus P; Maurin S; Boutte P; Mariani R
    Arch Fr Pediatr; 1982 Nov; 39(9):671-5. PubMed ID: 7165461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of two long-acting theophylline preparations in daily evening administration].
    Holzer R
    Wien Med Wochenschr; 1993; 143(2):37-42. PubMed ID: 8488685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of long-term oral administration of a sustained release theophylline preparation in children with chronic asthma.
    Cantani A; Businco E; Businco L; Solano A; Calabretta C
    Allergol Immunopathol (Madr); 1983; 11(1):11-4. PubMed ID: 6858803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sustained-action oral theophylline in the asthmatic child. Clinical, pharmacokinetic and respiratory function studies].
    Baculard A; Morgant G; Gaultier C; Boule M; Tournier G
    Rev Fr Mal Respir; 1983; 11(6):833-46. PubMed ID: 6669796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term stability of morning serum theophylline level in asthma patients under minimally 1-year therapy with Euphylong].
    Siebert B; Kunkel G; Staudinger HW; Böhm A; Steinijans VW
    Pneumologie; 1991 Nov; 45 Suppl 4():848-52. PubMed ID: 1812478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.